Ralph B D'Agostino Selected Research

HDL Cholesterol

1/2019	Quantifying Importance of Major Risk Factors for Coronary Heart Disease.
4/2017	Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study.
1/2016	Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
10/2015	Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
6/2015	Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality.
2/2015	Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease.
12/2014	Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
9/2014	Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.
9/2013	High-density lipoproteins: a consensus statement from the National Lipid Association.
6/2013	Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralph B D'Agostino Research Topics

Disease

68	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2002
37	Hypertension (High Blood Pressure) 01/2020 - 02/2002
34	Neoplasms (Cancer) 11/2021 - 01/2007
34	Type 2 Diabetes Mellitus (MODY) 11/2021 - 08/2002
32	Insulin Resistance 01/2015 - 08/2002
30	Atherosclerosis 01/2018 - 04/2003
27	Myocardial Infarction 01/2019 - 01/2000
26	Heart Failure 05/2021 - 03/2003
26	Stroke (Strokes) 01/2021 - 06/2002
24	Coronary Disease (Coronary Heart Disease) 10/2017 - 03/2003
23	Obesity 09/2014 - 08/2003
20	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 03/2009
18	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 04/2003
17	Breast Neoplasms (Breast Cancer) 11/2021 - 07/2011
17	Inflammation (Inflammations) 01/2021 - 07/2004
17	Diabetes Mellitus 01/2019 - 05/2006
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 08/2002
13	Glucose Intolerance 01/2010 - 08/2002
11	Dyslipidemias (Dyslipidemia) 11/2021 - 04/2003
9	Chronic Renal Insufficiency 01/2019 - 05/2007
9	Atrial Fibrillation 01/2018 - 12/2003
7	Hemorrhage 05/2017 - 10/2004
6	Neoplasm Metastasis (Metastasis) 11/2021 - 12/2006
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2009 - 10/2002
6	Overweight 03/2009 - 09/2002
6	Dementia (Dementias) 05/2008 - 02/2002
5	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 02/2007
5	Ischemic Stroke 01/2018 - 08/2003
5	Peripheral Arterial Disease 01/2018 - 07/2004
5	Infections 03/2013 - 06/2004
4	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2018
4	Brain Neoplasms (Brain Tumor) 01/2020 - 03/2006
4	Acute Coronary Syndrome 01/2018 - 03/2012
4	Thrombosis (Thrombus) 05/2017 - 04/2004
4	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017 - 08/2006
4	Isolated Systolic Hypertension 01/2016 - 08/2004
4	Carotid Stenosis (Carotid Artery Stenosis) 09/2009 - 07/2005
3	Lymphoma (Lymphomas) 01/2020 - 08/2017
3	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 08/2017
3	Cardiotoxicity 01/2019 - 09/2010
3	Hyperlipidemias (Hyperlipidemia) 01/2018 - 02/2015
3	Progeria (Hutchinson Gilford Syndrome) 01/2018 - 07/2016
3	Vascular Diseases (Vascular Disease) 01/2018 - 03/2003
3	Infarction (Infarctions) 06/2017 - 02/2003

Drug/Important Bio-Agent (IBA)

45	HDL CholesterolIBA 01/2019 - 10/2002
33	CholesterolIBA 01/2018 - 10/2002
33	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2002
28	LipidsIBA 11/2021 - 01/2000
27	Triglycerides (Triacylglycerol)IBA 11/2021 - 03/2003
26	C-Reactive ProteinIBA 11/2019 - 10/2002
24	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2005
19	Insulin (Novolin)FDA Link 09/2014 - 08/2002
14	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2000
14	LDL CholesterolIBA 10/2019 - 02/2005
13	oxidized low density lipoproteinIBA 11/2021 - 05/2003
12	Fibrinogen (Factor I)FDA Link 11/2019 - 04/2003
11	CalciumIBA 01/2021 - 03/2006
11	Lipoproteins (Lipoprotein)IBA 01/2017 - 03/2003
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2004
10	HomocysteineIBA 03/2011 - 02/2002
9	Interleukin-6 (Interleukin 6)IBA 11/2019 - 03/2003
9	CreatinineIBA 01/2019 - 12/2003
8	AnthracyclinesIBA 01/2020 - 11/2014
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 04/2014
8	ApolipoproteinsIBA 01/2019 - 03/2002
6	Biological ProductsIBA 01/2021 - 04/2006
6	Pharmaceutical PreparationsIBA 01/2020 - 09/2007
6	lipoprotein cholesterolIBA 03/2016 - 02/2005
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 01/2006
6	PotassiumIBA 05/2014 - 02/2003
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 08/2007
5	Alanine Transaminase (SGPT)IBA 12/2008 - 10/2004
5	Hemostatics (Antihemorrhagics)IBA 02/2006 - 11/2002
4	Hemoglobins (Hemoglobin)IBA 08/2021 - 05/2007
4	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 12/2012
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2000
4	Cystatin CIBA 01/2019 - 03/2014
4	AdiponectinIBA 11/2018 - 08/2008
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 04/2006
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2017 - 10/2004
4	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2017 - 01/2012
4	ORALIT (ORS)IBA 06/2013 - 04/2007
4	AdipokinesIBA 04/2011 - 08/2008
4	AlbuminsIBA 03/2009 - 03/2005
3	Hormones (Hormone)IBA 01/2021 - 06/2010
3	CarbohydratesIBA 11/2020 - 12/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2010
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 08/2007
3	lonafarnib (SCH 66336)IBA 01/2018 - 07/2016
3	thienopyridineIBA 05/2017 - 01/2016
3	Apolipoproteins B (ApoB)IBA 03/2016 - 08/2007
3	Adenosine Triphosphate (ATP)IBA 07/2015 - 08/2003

Therapy/Procedure

31	Therapeutics 01/2021 - 08/2002
15	Drug Therapy (Chemotherapy) 05/2021 - 06/2008
10	Glycemic Control 11/2021 - 03/2009
9	Radiotherapy 01/2020 - 12/2006
6	Catheters 01/2019 - 09/2010
3	Immunotherapy 11/2021 - 01/2020
3	Secondary Prevention 01/2018 - 07/2017